More than two billion people worldwide live with overweight or obesity, conditions closely linked to an array of health ...

Claiming Science magazine's breakthrough of the year in 2023 , these drugs are an absolute revelation: they give you ...

Discover the inspiring weight loss journey of a dietitian who overcame PCOS and pregnancy challenges to achieve lasting ...

Other approaches that are in development include fibroblast growth factor (FGF) mimetics such as FGF21-targeting candidates ...

There are now more than 300 GLP-1Rs in an active stage of development, from industry giants and potential market disrupters.

A new study finds semaglutide is linked to an increased risk of vision loss associated with a rare eye condition, but cases ...

There are more than 300 GLP-1Rs in an active stage of development, from industry giants and potential market disrupters.

These weight management drugs, which mimic natural hormones that regulate insulin and glucose levels, have become increasingly popular due to their effectiveness in promoting weight loss. However, ...

Weight loss tops many folks' list of New Year's resolutions, and lots of people are turning to cutting-edge weight-loss drugs ...

This may start to bring down the cost of brand-name competitors—here's who might get access, and one major difference from ...

Figuring out if GLP-1s are the right fit for you isn’t something to tackle alone—and that’s where Mochi Health comes in.

Generic Victoza is a GLP-1 receptor agonist indicated to improve glycemic control in adults and pediatric patients aged 10 ...